@article{26629, keywords = {Mapping, Epidemiology, Diagnoses}, author = {Marks M and Mitjà O and Solomon A and Asiedu K and Mabey D}, title = {Yaws.}, abstract = {
INTRODUCTION: Yaws, caused by Treponema pallidum ssp. pertenue, is endemic in parts of West Africa, Southeast Asia and the Pacific. The WHO has launched a campaign based on mass treatment with azithromycin, to eradicate yaws by 2020.
SOURCES OF DATA: We reviewed published data, surveillance data and data presented at yaws eradication meetings.
AREAS OF AGREEMENT: Azithromycin is now the preferred agent for treating yaws. Point-of-care tests have demonstrated their value in yaws.
AREAS OF CONTROVERSY: There is limited data from 76 countries, which previously reported yaws. Different doses of azithromycin are used in community mass treatment for yaws and trachoma.
GROWING POINTS: Yaws eradication appears an achievable goal. The programme will require considerable support from partners across health and development sectors.
AREAS TIMELY FOR DEVELOPING RESEARCH: Studies to complete baseline mapping, integrate diagnostic tests into surveillance and assess the impact of community mass treatment with azithromycin are ongoing.
}, year = {2015}, journal = {British medical bulletin}, volume = {113}, pages = {91-100}, issn = {1471-8391}, url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350436/ }, doi = {10.1093/bmb/ldu037}, language = {eng}, }